|
PIK3C3 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.765600E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.803030E-01 |
| Normal-vs-AfricanAmerican |
2.276600E-01 |
| Normal-vs-Asian |
3.051800E-01 |
| Caucasian-vs-AfricanAmerican |
7.888400E-01 |
| Caucasian-vs-Asian |
4.473000E-01 |
| AfricanAmerican-vs-Asian |
4.279800E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.541180E-01 |
| Normal-vs-Female |
2.024600E-01 |
| Male-vs-Female |
7.124400E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.932800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.331810E-01 |
| Normal-vs-Age(61-80Yrs) |
1.215570E-01 |
| Normal-vs-Age(81-100Yrs) |
8.348000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.282190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.534600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.811400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.505800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.558200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.333000E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
2.266000E-01 |
| Normal-vs-Pheochromocytoma |
1.780230E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
2.634600E-01 |
| Paraganglioma-vs-Pheochromocytoma |
6.412400E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.622600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
6.389800E-01 |
|
|
